Company Filing History:
Years Active: 2009
Title: Edward Jerome Tanner: Innovator in Diagnostic Reagents
Introduction
Edward Jerome Tanner is a notable inventor based in Dollard-des-Ormeaux, Canada. He has made significant contributions to the field of diagnostic reagents, particularly in relation to prostate cancer. His work has implications for both the evaluation and prognosis of this disease.
Latest Patents
Tanner holds a patent for PSP94 diagnostic reagents and assays. This patent describes the presence of PSP94 in serum, where it can exist in a free form or be associated with a carrier protein. The bound form of PSP94 has been quantified in the blood of prostate cancer patients, demonstrating its utility in clinical evaluations. The patent includes diagnostic assays, methods, and kits for detecting the free form of PSP94, along with reagents such as antibodies that can bind to it.
Career Highlights
Edward Jerome Tanner is currently associated with Ambrilia Biopharma, Inc., where he continues to advance his research in diagnostic technologies. His work is pivotal in enhancing the understanding and detection of prostate cancer through innovative diagnostic methods.
Collaborations
Tanner collaborates with esteemed colleagues, including Jonathan Reeves and Chandra J Panchal. Their combined expertise contributes to the development of effective diagnostic solutions in the biopharmaceutical sector.
Conclusion
Edward Jerome Tanner's contributions to the field of diagnostic reagents are invaluable, particularly in the context of prostate cancer. His innovative work continues to pave the way for advancements in medical diagnostics.